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Abstract
Community-associated methicillin-resistant Staphylococcus aureus accounts for a large portion of the increased
staphylococcal disease incidence and can cause illness ranging from mild skin infections to rapidly fatal sepsis syndromes.
Currently, we have limited understanding of S. aureus-derived mechanisms contributing to bacterial pathogenesis and host
inflammation during staphylococcal disease. Herein, we characterize an influential role for the saeR/S two-component gene
regulatory system in mediating cytokine induction using mouse models of S. aureus pathogenesis. Invasive S. aureus
infection induced the production of localized and systemic pro-inflammatory cytokines, including tumor necrosis factor
alpha (TNF-a), interferon gamma (IFN-c), interleukin (IL)-6 and IL-2. In contrast, mice infected with an isogenic saeR/S
deletion mutant demonstrated significantly reduced pro-inflammatory cytokine levels. Additionally, secreted factors
influenced by saeR/S elicited pro-inflammatory cytokines in human blood ex vivo. Our study further demonstrated robust
saeR/S-mediated IFN-cproduction during both invasive and subcutaneous skin infections. Results also indicated a critical
role for saeR/S in promoting bacterial survival and enhancing host mortality during S. aureus peritonitis. Taken together, this
study provides insight into specific mechanisms used by S. aureus during staphylococcal disease and characterizes a
relationship between a bacterial global regulator of virulence and the production of pro-inflammatory mediators.
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Introduction
Staphylococcus aureus predominates as a global cause of bacterial
infections, which can range from mild skin irritations to severe life-
threatening invasive disease [1]. Increases in reported cases of
methicillin-resistant S. aureus infections (MRSA) including com-
munity-associated MRSA (CA-MRSA) infections that occur in
otherwise healthy individuals, independent of hospital settings [2–
4], are an important public health concern. Generally presenting
with soft tissue infections, S. aureus disease is also associated with
such severe conditions as septicemia, necrotizing pneumonia and
necrotizing fasciitis [3,5–8]. In 2005, the United States reported
over 18,000 deaths resulting from invasive MRSA disease, a
number surpassing the annual fatalities associated with HIV/
AIDS [9,10].
Gram-positive bacterial infections account for ,50% of all
reported sepsis cases and are associated with the dysfunctional
production of pro-inflammatory cytokines [11–14]. Systemic S.
aureus infections are associated with the endogenous production of
interferon gamma (IFN-c), tumor necrosis factor alpha (TNF-a)
and interleukin (IL)-6 [15,16]. Additionally, innate immune
effectors exhibit severely diminished anti-bacterial function during
sepsis and S. aureus infections [17–21]. However, studies charac-
terizing pathogen-derived mediators of the host inflammatory
response have predominately focused on single toxins and
proteins, rendering the inflammatory modulating effects of global
virulence regulators undefined.
S. aureus possesses 16 two-component gene-regulatory systems
that monitor changing environmental conditions to influence gene
transcription [22–24]. Numerous studies have indicated a
regulatory role for the S. aureus two-component system SaeR/S
in the expression of secreted virulence factors [25–33]. Previous
findings have demonstrated a critical role for saeR/S in evading
destruction by neutrophils and enhancing mortality in murine
bacteremic models [18,33]. However, significant gaps in our
understanding of how saeR/S contributes to S. aureus pathogenesis
exist. To that end, we investigated the influence of saeR/S on
pathogen survival and the host response during invasive disease
and demonstrated that saeR/S strongly influenced the production
of inflammatory cytokines during S. aureus infection. These current
findings further support the hypothesis that saeR/S is a critical
mediator of pathogenesis during staphylococcal disease.
Results
SaeR/S significantly enhances S. aureus survival,
dissemination and mortality during invasive disease
Invasive staphylococcal disease is associated with bacterial
persistence and dissemination to deep tissues. To investigate the
effects of saeR/S on bacterial survival and dissemination during
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via intraperitoneal (i.p.) inoculation with wild-type (MW2) or S.
aureus with deleted saeR/S (MW2DsaeR/S) (figure 1). At 4 hours
post-infection, saeR/S did not impact S. aureus survival in the
peritoneum, as both MW2- and MW2DsaeR/S-infected mice
exhibited similar bacterial loads (P.0.05; figure 1A). However, at
10 hours post-infection, saeR/S-regulated factors significantly
increased S. aureus survival in the peritoneum of MW2-infected
mice (P,0.0001; figure 1B). To further investigate the contribu-
tions of saeR/S on S. aureus tissue infiltration, we harvested both
kidneys and enumerated S. aureus burdens at 10 hours post-
infection. Mice infected with MW2DsaeR/S had significantly less
colony forming units (cfu) in the kidneys (P,0.0001; figure 1C),
suggesting a role for saeR/S in pathogen dissemination. To
characterize the influence of saeR/S on S. aureus dissemination
from the infectious foci, we exsanguinated mice and harvested
hearts for additional S. aureus quantification. Consistent with
peritoneal cavity and kidney burdens, the absence of saeR/S
significantly reduced bacterial loads in the hearts from
MW2DsaeR/S-infected mice (P,0.01; figure 1D). Surprisingly,
both groups exhibited similar S. aureus burdens in the blood
(P.0.05; figure 1E). This suggests a transient presence of S. aureus
in the blood following peritonitis. Consistent with observations of
the influence of saeR/S on murine mortality during S. aureus
bacteremia [18,33], saeR/S-regulated factors significantly en-
hanced morbidity and mortality in the peritonitis model (1 mouse
infected with MW2 survived the 72 hours time course, compared
to 8 mice infected with MW2DsaeR/S; P,0.001; figure 1F). These
results are congruent with previous observations that saeR/S
contributes to host mortality [18,33] and demonstrates saeR/S is
essential for S. aureus survival and dissemination following invasive
infection.
SaeR/S promotes pro-inflammatory cytokine gene
transcription
Sepsis syndromes are commonly associated with an early rapid
induction of pro-inflammatory cytokines [13]. Following i.p.
infection with MW2 and MW2DsaeR/S, we investigated the
influence of saeR/S-regulated factors on the transcriptional
regulation of 84 host-derived inflammation-associated genes
(Tables 1, S1 and S2). Leukocytes were isolated from the
peritoneal cavity at 4 hours post-inoculation, when the bacterial
burdens between MW2 and MW2DsaeR/S were virtually equal
(figure 1A). Deletion of saeR/S resulted in a down-regulation of key
inflammatory cytokines (Tables 1 and S1). Of the 84 assayed
genes, 47 were down-regulated $3-fold with only 6 genes up-
regulated $3-fold, MW2DsaeR/S relative to MW2 (Tables 1 and
S1). Several pro-inflammatory genes commonly expressed during
early sepsis were down-regulated in MW2DsaeR/S-infected mice
compared to MW2-infected mice, including: IFN-c: -11.27-fold
(P#.05), TNF: -9.37-fold (P.0.10), IL-18: 27.17 (P#0.01), CD40
ligand: 24.92 (P#0.01), IL-1b: 24.07 (P#0.05) and C-reactive
protein: 24.43 (P#0.05) (Tables 1 and S1). Interestingly,
transcription of anti-inflammatory cytokine genes were relatively
unaffected with the exception of IL1RII, which was up-regulated
21.38-fold, MW2DsaeR/S relative to MW2 (Table S1). Both MW2
Figure 1. SaeR/S promotes bacterial persistence and host mortality in a mouse model of S. aureus peritonitis. Mice were inoculated i.p.
with MW2 or MW2DsaeR/S (5610
7 cfu) for (A) 4 hours and (B–E) 10 hours. (A) S. aureus burden in the peritoneal exudate, NS. For data in (A), results
are from 3 biological replicates of 5 mice/group (n=15). (B) S. aureus burden in peritoneal exudate, ****P,0.0001. (C) S. aureus burden in the kidneys,
****P,0.0001. (D) S. aureus burden in the heart, **P,0.01. E, S. aureus burden in the blood, NS. For data in (B–E), results are from 2 biological
replicates of 7 and 8 mice/group (n=15). All tissues compared were individually analyzed by t test. (F) Survival curve for mice inoculated (i.p.) with
5610
7 cfu of MW2 or MW2DsaeR/S,* P,0.001 as determined by logrank test (n=10/group). Mice receiving PBS had no S. aureus cfu (data not shown).
NS=not significant.
doi:10.1371/journal.pone.0019939.g001
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cytokine transcription compared to PBS-inoculated control mice
(Table S2). These results suggest differences in transcriptional
activity stem from saeR/S-regulated factors, and indicate a saeR/S-
mediated pro-inflammatory cytokine response during S. aureus
infection.
SaeR/S-regulated factors promote pro-inflammatory
cytokines in the blood during invasive disease
Sepsis and septic shock are associated with the systemic
production of inflammatory cytokines [11–14]. To determine if
the saeR/S-mediated inflammatory response was systemic during
S. aureus peritonitis, we infected mice i.p. with 5610
7 cfu of MW2
or MW2DsaeR/S for 10 hours and measured protein levels of
several pro- and anti-inflammatory cytokines in the serum by
cytometric bead array (figure 2). Of note, serum IFN-cand TNF
levels were significantly reduced in mice infected with
MW2DsaeR/S (P,0.05 and P,0.01, respectively; figures 2Aa n d
2B). Additional pro-inflammatory cytokines associated with sepsis
syndromes were influenced by saeR/S as serum IL-6 and IL-2
concentrations were significantly lower in MW2DsaeR/S-infected
mice (P,0.01; figure 2C and 2D). Serum IL-17A levels were also
significantly reduced in mice infected with MW2DsaeR/S
(P,0.01; figure 2E). In contrast, IL-4 and IL-10 serum
concentrations did not exhibit differences between MW2 and
MW2DsaeR/S-infected groups (P.0.05; figures 2F and 2G).
These results are consistent with previous sepsis syndrome
observations, in which an early pro-inflammatory cytokine
response (IFN-c, TNF, IL-2, and IL-6) was concomitant with a
relatively subdued anti-inflammatory cytokine (IL-4 and IL-10)
response [13,14]. The differentially regulated transcriptional
activity in the peritoneum (Tables 1 and S1) and the polarized
pro-inflammatory cytokine response in the blood (figure 2)
indicate that saeR/S-regulated factors promote localized and
systemic inflammation during invasive disease.
Secreted factors, regulated by saeR/S, significantly
enhance the production of inflammatory proteins in
human whole blood
Numerous secreted S. aureus virulence factors are regulated by
saeR/S [25–33]. To investigate the concerted role of these
exoproteins on the production of cytokines in human blood and
to confirm the saeR/S-mediated production of IFN-c,T N F ,I L -
6, IL-2 and IL-17A observed in mice (figure 2 and Table 1), we
treated human whole blood with supernatants from cultures of
MW2, MW2DsaeR/S and a saeR/S-complemented MW2DsaeR/
S strain (MW2DsaeR/Scomp) and compared plasma cytokine
levels (figure 3). The data shown are normalized for each
individual donor to account for large variations in the
magnitude of cytokine expression between individuals. Consis-
tent with cytokine profiles observed in our mouse studies, MW2-
treated human blood produced significantly higher levels of
IFN-cand TNF compared to MW2DsaeR/S-treated blood
(P,0.05; figures 3Aa n d3 B ). Treatment with MW2DsaeR/
Scomp supernatant restored the observed IFN-cphenotype and
partially restored the TNF phenotype (figures 3Aa n d3 B ,
respectively). IL-2 and IL-6 levels were also significantly
elevated in the MW2 treatment groups (P,0.05; figures 3C
and 4D, respectively), whereas IL–17A was not significantly
influenced by supernatants within treatment groups (data not
shown). Control groups (media-treated and no treatment) did
not result in substantial production of the assayed proteins (data
not shown). These results demonstrate that saeR/S-regulated
secreted factors stimulate the production of pro-inflammatory
cytokines in human blood.
The absence of SaeR/S significantly attenuates
production of localized IFN-c and TNF-a production
To further investigate the role of saeR/S-mediated factors on the
production of IFN-c and TNF-a at the infectious foci, we
measured protein levels in the peritoneal exudates following i.p.
inoculation with MW2 or MW2DsaeR/S. At 10 hours post-
infection, IFN-c was significantly reduced in mice infected with
MW2DsaeR/S compared to MW2, following i.p. inoculation with
5610
7 cfu (P,0.001; figure 4B). Significant increases in IFN-c
production in MW2 compared to MW2DsaeR/S were also
observed using a ten-fold decrease in i.p. inoculum (5610
6 cfu;
P,0.05; figure 4B). Of note, mice infected with 5610
6 MW2 cfu
produced significantly higher IFN-c concentrations compared to
mice infected with 5610
7 MW2DsaeR/S cfu (P,0.01; figure 4B).
This demonstrates that differences in bacterial burden (figure 4A)
do not account for the observed decrease in IFN-c in MW2DsaeR/
S-infected mice and that the robust IFN-c production is saeR/S-
mediated. TNF-a protein was also significantly elevated in mice
infected with MW2 compared to MW2DsaeR/S, for both 5610
7
and 5610
6 cfu inoculums (P,0.01; figure 2C). Collectively, these
findings demonstrate that saeR/S-regulated factors elicit the
production of IFN-c and TNF-a at the infectious foci during
invasive S. aureus infection.
Table 1. SaeR/S-mediated factors elicit host pro-inflammatory transcription during invasive disease.
Gene symbol Encoded protein
Fold-regulation
change P value
ifng Interferon gamma 211.27 #0.05
tnfrsf1a Tumor necrosis factor receptor superfamily, member 1a 23.03 #0.01
il18 Interleukin 18 27.17 #0.01
cd40lg CD40 ligand 24.92 #0.01
il1b Interleukin-1b 24.07 #0.05
crp C-reactive protein 24.43 #0.05
il11 Interleukin 11 23.65 #0.05
NOTE. Genes listed display fold-regulation values of MW2DsaeR/S-infected mice relative to MW2-infected mice (3 per group). RNA was collected from all leukocytes
isolated from the peritoneum, 4 hours post-infection. Fold-regulation and P values calculated using SA Biosciences
TM web-based software utilizing the DDCt method.
doi:10.1371/journal.pone.0019939.t001
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MW2DsaeR/S (5610
7 cfu) or PBS for 10 hours and serum cytokine concentrations were measured by cytometric bead array. Serum concentrations
(pg/ml) of (A) IFN-c,( B) TNF, (C) IL-6, (D) IL-2, (E) IL-17A, (F) IL-10 and (G) IL-4. Results displayed are from 5 mice (MW2), 7 mice (MW2DsaeR/S) and
2 mice (PBS). *P,0.05 and **P,0.01 compared to cytokine expression in MW2-infected mice for each cytokine investigated as determined by t test.
NS=not significant; N/D=not detectable.
doi:10.1371/journal.pone.0019939.g002
Figure 3. Secreted factors influenced by saeR/S promote inflammatory cytokines in human whole blood. S. aureus supernatants were
collected at early stationary growth phase. Human whole blood was exposed to diluted S. aureus supernatants from MW2, MW2DsaeR/S and
MW2DsaeR/Scomp strains. Cytokine levels were measured after 3 hours. Results represent the blood plasma concentration ratios of (A) IFN-c,( B) TNF,
(C) IL-6 and (D) IL-2. Ratios represent the concentration of protein measured in MW2, MW2DsaeR/S or MW2DsaeR/Scomp-treated whole blood to the
concentration measured in MW2DsaeR/S-treated blood, normalized for each donor. Protein concentrations were measured by cytometric bead array.
Results are from 4 separate donors. *P,0.05 versus MW2 as measured by ANOVA with Tukey’s post-test. NS=not significant.
doi:10.1371/journal.pone.0019939.g003
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S. aureus pulsed-field gel electrophoresis type USA300 (LAC) is a
major cause of CA-MRSA skin infections [34]. To investigate if
saeR/S promotes IFN-c during skin infection and to confirm our
previous observation that IFN-c production is influenced by saeR/
S-regulated factors, we infected mice subcutaneously with LAC
and an isogenic deletion mutant of saeR/S (LACDsaeR/S) [33]. At
8 hours post-infection, the deletion of saeR/S did not impact
bacterial load at the site of infection (Figure 5A). These findings are
consistent with our previous studies demonstrating saeR/S does not
significantly influence abscess size or S. aureus burden during early
skin infection (i.e. less than two days) [18,33]. However, saeR/S did
promote a significant increase in IFN-c in LAC-infected mice
compared to LACDsaeR/S-infected mice (P,0.05; Figure 5B).
IFN-c concentrations in un-infected mouse skin tissues were
undetectable (Figure 5B). These data are consistent with our
observations of enhanced IFN-c during peritonitis (figure 4) and
are in further support that robust IFN-c production observed
during S. aureus disease is saeR/S-mediated.
Discussion
In the current study, we found that absence of saeR/S
significantly decreased the localized and systemic production of
pro-inflammatory mediators (i.e. TNF-a, IFN-c, IL-1b, IL-2, IL-6
and IL-17A) during invasive staphylococcal disease (Tables 1, S1
and figures 2–4). We also observed that robust IFN-c production
was saeR/S-mediated during both S. aureus peritonitis and
superficial skin infections (Table 1 and figures 4 and 5).
Significantly elevated systemic pro-inflammatory cytokines cou-
pled with the onset of mortality in wild-type-infected mice strongly
indicate that saeR/S is critical for mediating sepsis, a phenotype
absent in mutant-infected groups. This conclusion is supported by
the ‘cytokine storm’ hypothesis, a phenomena characterized by a
rapid pro-inflammatory cytokine response that correlates very
strongly with coagulation dysfunction, organ failure and death
[35,36]. Our observation demonstrating both pro-inflammatory
transcript abundance and protein concentration as significantly
elevated in MW2-infected groups (figures 2–4 and Tables 1 and
S1), when bacterial burdens are virtually equal at the sites of
inflammation (figures 1A, 1E and 4A), suggest pro-inflammatory
cytokine production stems from saeR/S-regulated factors. This idea
is further supported by our data demonstrating IFN-c production
Figure 4. SaeR/S significantly increases IFN-cand TNF-a at the site of infection during invasive disease. Mice were inoculated i.p. with
MW2 or MW2DsaeR/S (5610
7 or 5610
6 cfu) for 10 hours. (A) Bacterial burden in peritoneal exudates. Concentrations (pg/ml) of (B) IFN-cand (C) TNF-a
in peritoneal exudates. *P,0.05, **P,0.01 and ***P,0.001 compared to MW2 in each panel as determined by t test. Protein levels for uninfected
tissue controls were undetectable. Results are from 7 mice/group for high bacterial infection (5610
7 cfu), 8 mice/group for 10-fold reduced bacterial
infection (5610
6 cfu) and 5 mice in the PBS group. N/D=not detectable.
doi:10.1371/journal.pone.0019939.g004
Figure 5. Skin infection with LAC induces IFN-c in a saeR/S-
dependent manner. Mice were inoculated subcutaneously with LAC,
LACDsaeR/S (1610
7 cfu) or DPBS for 8 hours. Infected tissues were
excised and homogenized for bacterial load enumeration and IFN-c
concentration measurements. (A) Bacterial burden at the site of
infection. (B) IFN-c concentration (pg/g tissue) in affected tissues.
*P,0.05 compared to MW2 in each panel as determined by t test.
Results are from 3 biological replicates of 3 mice/group (n=9) and
2 mice/PBS group (n=6). NS=not significant; N/D=not detectable.
doi:10.1371/journal.pone.0019939.g005
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compared to MW2, even when the bacterial burden in mutant
S. aureus-infected mice is significantly increased (,10-fold) over
wild-type S. aureus-infected mice (figures 4A and 4B). These data
suggest factors regulated by saeR/S are responsible for the robust
IFN-c response observed during S. aureus infection. However,
additional studies are needed to define the contribution of other S.
aureus global regulators of virulence in mediating the production of
IFN-c and other pro-inflammatory cytokines.
During S. aureus infection, the role of IFN-c has been disputed
with studies demonstrating that this inflammatory mediator plays
either protective or deleterious roles. For example, using a surgical
wound model, McLoughlin et al [37] reported that in the absence
of IFN-c, a decreased S. aureus burden was observed at the site of
infection. Zhao et al [38] observed that monoclonal antibody-
neutralization of IFN-c decreased the frequency and severity of S.
aureus-mediated arthritis. Using IFN-c-deficient mice, Sasaki et al
[39] reported a decrease in S. aureus burden and an increase in
survival rates using a bacteremic model of infection. Conversely,
others have demonstrated that administration of exogenous IFN-c
decreased mouse mortality and reduced bacterial loads following
S. aureus bacteremia [38,40]. Our current findings correlate
increased IFN-c with elevated bacterial burdens and increased
morbidity and mortality. However, it is likely that the observed
effects of IFN-c during S. aureus disease are dependent upon
multiple factors, including strain of S. aureus studied and type/
route of infection. Clearly, additional studies are necessary to
characterize the precise role of IFN-c as a mediator of S. aureus
pathogenesis.
S. aureus produces several factors that have been implicated in
pro-inflammation, including superantigens and exotoxins [41].
Superantigens non-specifically bind the major histocompatibility
complex type II (MHCII) of antigen-presenting cells to T-cell
receptors, causing massive T-cell activation and release of pro-
inflammatory cytokines [42]. SaeR/S regulates several of these
factors (18, 33, 43]. For example, Pantrangi et al [43] showed
saeR/S to positively regulate staphylococcal superantigen-like
genes ssl5 and ssl8. Staphylococcal enterotoxin C exhibits a
superantigenic phenotype and is also regulated by saeR/S [18,44].
SaeR/S also regulates exotoxin/cytolysin production (i.e. hla and
hlg) and these factors elicit pro-inflammatory cytokines [18,33,45].
Finally, our previous study showed that saeR/S-regulated factors
significantly enhanced the lysis of neutrophils [18]. Cellular lysis
promotes the release of host-derived intracellular components and
peripheral leukocytes may recognize these danger-associated
molecular patterns (DAMPs) to further perpetuate the pro-
inflammatory response [46]. Thus, saeR/S regulates a full
repertoire of factors capable of eliciting a dysfunctional pro-
inflammatory cytokine response, an essential mechanism of sepsis.
In addition to saeR/S, other S. aureus regulatory systems play
pivotal roles in virulence and inflammation during infection. Both
agr and sarA are essential for full virulence during invasive S. aureus
disease [47,48]. Heyer et al [49] explored the role of agr- and sarA-
mediated cytokine production in a murine model of S. aureus
pneumonia and reported neither regulator was required for the
production of IL-8, a potent pro-inflammatory mediator of
neutrophil recruitment. However, both agr and sarA did promote
granulocyte-macrophage colony-stimulating factor (GM-CSF), a
cytokine implicated in global pro-inflammatory responses during
invasive infection [49]. Furthermore, agr has been shown to elicit
cytokines and chemokines, important in leukocyte trafficking, from
endothelial cells [50]. Taken together with our current report,
these studies support the hypothesis that robust host inflammatory
responses result from pathogen-derived factors under the influence
of global regulators. However, more studies are needed to
indentify the specific S. aureus factors responsible for the pro-
inflammatory response.
In the current study, we report key pro-inflammatory cytokines,
associated with sepsis syndromes, as being induced in response to
factors regulated by the S. aureus two-component gene regulatory
system, saeR/S. We hypothesize that saeR/S plays a critical role in
S. aureus pathogenesis during invasive disease, likely through a
synergistic mechanism of innate immune evasion [25] and the
initiation of potentially dysfunctional host inflammatory pathways.
This study provides a foundation for future work to identify the
individual contributions of specific saeR/S-regulated factors to the
host inflammatory response during staphylococcal disease.
Materials and Methods
Bacterial strains and culture
S. aureus isolates, pulsed-field gel electrophoresis type USA400
(MW2) and pulsed-field gel electrophoresis type USA300 (LAC),
were selected based on clinical relevance [5–11,17,18,33,51–54].
S. aureus was cultured in tryptic soy broth (TSB) supplemented with
0.5% glucose and harvested as described elsewhere [17]. MW2,
MW2saeR/S and MW2DsaeR/Scomp were generated in prior
investigations [18]. LAC and LACDsaeR/S were generated in
prior investigations [33].
Mouse infection models
All animal studies were performed in accordance with the
National Institutes of Health guidelines and approved by the
Animal Care and Use Committee at Montana State University-
Bozeman. For the peritonitis model, male and female BALB/c
mice (aged 8–10 weeks) were purchased from commercial sources
and the Montana State University Animal Resource Center. S.
aureus was harvested at mid-exponential growth phase, washed in
sterile Dulbecco’s phosphate buffered saline (DPBS) and re-
suspended in sterile DPBS at a concentration of 5610
6 or 56cells
per 100 ml. All mice were inoculated via intraperitoneal route (i.p.)
with MW2 or MW2DsaeR/S and control mice received sterile
DPBS.
Bacterial burdens were determined as follows: to enumerate S.
aureus in the peritoneum, the peritoneal cavity was washed with
10 ml sterile HANKs’ balanced salt solution using an 18 gauge
needle and 10 ml syringe. Exudate was diluted in distilled water
(dH20) and plated on tryptic soy agar (TSA) plates for enumeration
of colony forming units (cfu). To determine S. aureus load in the
blood, mice were anesthetized in isoflurane then exsanguinated via
the axillary vessels. Blood was diluted in dH20 and plated on TSA.
To determine S. aureus burden in selected organs, hearts and both
kidneys were aseptically removed, washed in dH20 and then
homogenized in dH2O. Homogenates were diluted in dH2O and
plated on TSA. TSA plates were incubated overnight in 37uC; 5%
CO2 and cfu counted the following day.
The survival study was performed by inoculating mice i.p. with
5610
7 S. aureus. Mice were monitored every 2 hours for 48 hours
and then every 4 hours for an additional 24 hours. Mice were
euthanized if they became immobile, exhibited labored breathing
or were unable to eat or drink. Survival statistics were performed
using a log-rank test.
Skin infection models were performed as described elsewhere
[18,33]. Crl;SKH1-hrBR hairless mice (Charles River) were
inoculated subcutaneously with 1610
7 bacteria. Eight hours
post-bacterial inoculation, the infected skin area was excised using
a 9 mm diameter ‘‘punch.’’ Tissues were homogenized in sterile
SaeR/S Induces Pro-Inflammatory Cytokines
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ELISA per the manufacturer’s instructions (R&D Systems).
Mouse inflammatory gene expression
To compare host inflammatory transcript levels, mice were
inoculated i.p. with 5610
7 MW2 or MW2DsaeR/S or control
DPBS for 4 hours. Peritoneal cavities were washed as described
above, and the exudate was centrifuged for 5 min at 600 x g.
Pellets were resuspended in RLT lysing buffer (Qiagen) and RNA
was purified using RNeasy kits as described by the manufacturer
(Qiagen). Contaminating DNA was digested on-column using
DNase (Qiagen). Complementary DNA (cDNA) was synthesized
using ,200 ng purified RNA and C-03 RT
2 First Strand Kit (SA
Biosciences). Detection of cDNA was performed using RT
2 Real-
time
TM SYBR Green/ROX PCR master mix (SA Biosciences).
Master mix with cDNA was loaded onto the Mouse Inflammatory
Cytokines and Receptors RT
2 Profiler
TM PCR Array (SA
Biosciences). Real-time PCR was performed using a 7500 Fast
Real-time PCR system with Fast Real-time PCR system software
v1.4.0 (Applied Biosystems). Calculated threshold (Ct) values were
uploaded to the manufacturer’s website (SA Biosciences; http://
www.sabiosciences.com/pcr/arrayanalysis.php) for analysis using
the DDCt method. Fold-regulation and P values were calculated by
SA Biosciences software (SA Biosciences; http://www.sabiosciences.
com). Gene analyses are displayed as fold-regulation values of
MW2DsaeR/S- i n f e c t e dmi c ere la t iv et oM W 2 - i n f e c t e dmi c e(T a b l e s1
and S1) and MW2 or MW2DsaeR/S-infected mice relative to DPBS-
treated mice (Table S2).
Mouse cytokine assays
TNF-a and IFN-c concentrations in peritoneal exudates were
measured using sandwich ELISA per the manufacturer’s instruc-
tions (R&D Systems). Mouse blood was collected as described
above, and mouse serum was separated from whole blood by
centrifugation. Protein levels of IFN-c, TNF, IL-6, IL-2, IL-17a,
IL-4 and IL-10 were measured using mouse Th1/Th2/Th17
Cytometric Bead Arrays per the manufacturer’s instructions (BD
Biosciences). All results are displayed as mean concentrations 6
SEM (pg/ml).
Cytokine expression in human whole blood
Heparinzed venous human whole blood was collected from
healthy individuals in accordance with an approved protocol by
the Montana State University Institutional Review Board. Donors
provided written consent to participate in the study. Overnight S.
aureus cultures were inoculated in TSB at a ratio of 1:100 and
allowed to incubate for 6 hours to early stationary growth phase.
At this time, no differences in bacterial growth exist between S.
aureus strains (data not shown) [18]. Ten ml of S. aureus cell
suspension was pelleted by centrifugation, and 1 ml of supernatant
was sterile filtered using 0.22 mm syringe filters. Filtrate was plated
to ensure the absence of S. aureus (data not shown). Filtered S. aureus
supernatant was incubated with 1 ml human blood at final ratios
of 1:8, 1:16 and 1:32 using an end-over-end apparatus (Heto
Rotamix RK) at 20 RPM for 3 hours at 37uC and 10% CO2.
Plasma was isolated by centrifugation and stored at 280uC until
assayed for protein concentration using human Th1/Th2/Th17
Cytometric Bead Arrays per the manufacturer’s instructions (BD
Biosciences).
Statistical Analyses
All data sets were analyzed using GraphPad Prism, version 4.0c
for Macintosh (GraphPad Software, San Diego, CA). All mouse
data sets were analyzed using paired t tests (see figure legends).
Human blood data sets were analyzed using one-way analysis of
variance (ANOVA) with Tukey’s post-test. For bar graphs, error
bars represent the standard error of the mean. Mouse survival
statistics were analyzed using the log-rank test.
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Table S1 Genes listed display fold-regulation values of
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